80 related articles for article (PubMed ID: 24469723)
21. The Role of MicroRNA as Clinical Biomarkers for Breast Cancer Surgery and Treatment.
Davey MG; Davies M; Lowery AJ; Miller N; Kerin MJ
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361056
[TBL] [Abstract][Full Text] [Related]
22. The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer.
Adinew GM; Taka E; Mendonca P; Messeha SS; Soliman KFA
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33916931
[TBL] [Abstract][Full Text] [Related]
23. Exosomes derived from microRNA-512-5p-transfected bone mesenchymal stem cells inhibit glioblastoma progression by targeting JAG1.
Yan T; Wu M; Lv S; Hu Q; Xu W; Zeng A; Huang K; Zhu X
Aging (Albany NY); 2021 Mar; 13(7):9911-9926. PubMed ID: 33795521
[TBL] [Abstract][Full Text] [Related]
24. Prognostic role of microRNA 182 and microRNA 18a in locally advanced triple negative breast cancer.
Bajaj R; Tripathi R; Sridhar TS; Korlimarla A; Choudhury KD; Suryavanshi M; Mehta A; Doval DC
PLoS One; 2020; 15(11):e0242190. PubMed ID: 33175907
[TBL] [Abstract][Full Text] [Related]
25. Pathway Analysis of Selected Circulating miRNAs in Plasma of Breast Cancer Patients: A Preliminary Study.
Holubekova V; Kolkova Z; Grendar M; Brany D; Dvorska D; Stastny I; Jagelkova M; Zelinova K; Samec M; Liskova A; Laucekova Z; Kudela E; Bobrovska M; Kalman M; Zubor P; Dankova Z
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023154
[TBL] [Abstract][Full Text] [Related]
26. miR-7 Reverses Breast Cancer Resistance To Chemotherapy By Targeting MRP1 And BCL2.
Hong T; Ding J; Li W
Onco Targets Ther; 2019; 12():11097-11105. PubMed ID: 31908478
[TBL] [Abstract][Full Text] [Related]
27. miR-190-5p in human diseases.
Yu Y; Cao XC
Cancer Cell Int; 2019; 19():257. PubMed ID: 31624470
[TBL] [Abstract][Full Text] [Related]
28. Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity.
Gupta I; Sareyeldin RM; Al-Hashimi I; Al-Thawadi HA; Al Farsi H; Vranic S; Al Moustafa AE
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30871273
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-143 is Associated With Pathological Complete Response and Regulates Multiple Signaling Proteins in Breast Cancer.
García-Vázquez R; Marchat LA; Ruíz-García E; Astudillo-de la Vega H; Meneses-García A; Arce-Salinas C; Bargallo-Rocha E; Carlos-Reyes Á; López-González JS; Pérez-Plasencia C; Ramos-Payán R; Aguilar-Medina M; López-Camarillo C
Technol Cancer Res Treat; 2019 Jan; 18():1533033819827309. PubMed ID: 30755102
[TBL] [Abstract][Full Text] [Related]
30. Profiling of Invasive Breast Carcinoma Circulating Tumour Cells-Are We Ready for the 'Liquid' Revolution?
Braun M; Markiewicz A; Kordek R; Sądej R; Romańska H
Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30691008
[TBL] [Abstract][Full Text] [Related]
31. Dynamics of circulating microRNAs as a novel indicator of clinical response to neoadjuvant chemotherapy in breast cancer.
Zhu W; Liu M; Fan Y; Ma F; Xu N; Xu B
Cancer Med; 2018 Sep; 7(9):4420-4433. PubMed ID: 30099860
[TBL] [Abstract][Full Text] [Related]
32. MicroRNAs in regulation of triple-negative breast cancer progression.
Piasecka D; Braun M; Kordek R; Sadej R; Romanska H
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1401-1411. PubMed ID: 29923083
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum.
Thomas ML; Marcato P
Cancers (Basel); 2018 Apr; 10(4):. PubMed ID: 29614786
[TBL] [Abstract][Full Text] [Related]
34. The microRNAs miR-200b-3p and miR-429-5p target the LIMK1/CFL1 pathway to inhibit growth and motility of breast cancer cells.
Li D; Wang H; Song H; Xu H; Zhao B; Wu C; Hu J; Wu T; Xie D; Zhao J; Shen Q; Fang L
Oncotarget; 2017 Oct; 8(49):85276-85289. PubMed ID: 29156719
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of miRNA profiles for predicting pathological responses to neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer.
Ohzawa H; Miki A; Teratani T; Shiba S; Sakuma Y; Nishimura W; Noda Y; Fukushima N; Fujii H; Hozumi Y; Mukai H; Yasuda Y
Oncol Lett; 2017 Mar; 13(3):1731-1740. PubMed ID: 28454317
[TBL] [Abstract][Full Text] [Related]
36. Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancer.
Casey MC; Sweeney KJ; Brown JA; Kerin MJ
Int J Cancer; 2016 Jul; 139(1):12-22. PubMed ID: 26756433
[TBL] [Abstract][Full Text] [Related]
37. MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer.
Mathe A; Scott RJ; Avery-Kiejda KA
Int J Mol Sci; 2015 Nov; 16(12):28347-76. PubMed ID: 26633365
[TBL] [Abstract][Full Text] [Related]
38. Impact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological Cancer.
Krakowsky RH; Tollefsbol TO
Front Nutr; 2015; 2():16. PubMed ID: 26075205
[TBL] [Abstract][Full Text] [Related]
39. Association of microRNAs and pathologic response to preoperative chemotherapy in triple negative breast cancer: preliminary report.
Kolacinska A; Morawiec J; Fendler W; Malachowska B; Morawiec Z; Szemraj J; Pawlowska Z; Chowdhury D; Choi YE; Kubiak R; Pakula L; Zawlik I
Mol Biol Rep; 2014 May; 41(5):2851-7. PubMed ID: 24469723
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.
Ouyang M; Li Y; Ye S; Ma J; Lu L; Lv W; Chang G; Li X; Li Q; Wang S; Wang W
PLoS One; 2014; 9(5):e96228. PubMed ID: 24788655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
